Most cases of chronic lymphocytic leukaemia (CLL) and non-Hodgkin's lymphoma (NHL) represent a proliferation of neoplastic B lymphocytes (Grey et al., 1971) . Such cells are not generally regarded as secreting cells, and the majority of immunoglobulin (Ig) synthesized is for insertion into the plasma membrane (Stevenson, 1976) . However, recent studies of such lymphocytes in vitro have shown that some secretion of Ig does occur. In the majority of cases of CLL the secreted material has been shown to be free light chain (Maino et al., 1977; Gordon et al., 1978) often with small amounts of pentameric IgM . In NHL the pattern of secretion is more complex and appears to depend on the surface Ig isotypes, but a study by biosynthetic radiolabelling showed export of free monotypic light chain in 11 out of 27 patients (Hannam-Harris et al., 1980) . If neoplastic B lymphocytes are secreting light chain it may be found in urine as a monoclonal product and the amount found should reflect disease load. Normal urine contains light chains of both K and A types, which are polyclonal, and are excreted at a rate of 4mg per 24h (Hemmingsen & Skaarup, 1975) . Thus, examination of urine for monoclonal light chain is against a background of polyclonal products.
One method developed in this laboratory for isolating and identifying the tumour-related light Correspondence: F.K. Stevenson Received 12 December 1982; accepted 19 February 1983. chain has been described (Pierson et al., 1980) Tables  I and II. Most patients with CLL appeared to have  a B cell neoplasm by the demonstration of one light  chain type at the cell surface by immunofluorescence. The 2 patients with no detectable surface Ig showed monotypic light chain export in vitro when culture fluids were analyzed by radioimmunoassay thus demonstrating their B cell nature.
The NHL patients were classified by using the system described by Gerard-Marchant et al. (1974) with staging according to the Ann Arbor Conference (Carbone, 1971) (Table II (Isaacson et al., 1979) , 2 (RR and BW) were immunologically reactive without tumour involvement and one (JU) exhibited features of angioimmunoblastic lymphadenopathy (AILD) (Lukes & Tindle, 1975 and did not exceed 20%.
Isoelectric focusing Isoelectric focusing was carried out on composite agarose polyacrylamide plates. These were prepared by heating 0.35 g of IEF grade agarose (Pharmacia (Great Britain) Ltd., Hounslow, Middlesex) with 2.0 g of 10% non-crosslinked polyacrylamide in 38 ml distilled water, cooling to 75°C and adding 2 ml 40% carrier ampholytes pH 3.5-9.5 (LKBProdukter AB, Bromma, Sweden). The mixed gel was then poured into templates, overlaid with Gel Bond (FMC Corporation, Marine Colloids Division, Bioproducts, Rockland, Maine) and stored overnight at 4°C before use. Concentrated urine samples were centrifuged at 1500 g for 15 min and 5 ,l aliquots treated with glycine to give a 1% solution. Aliquots of 1-8 ,l were applied to the gel. Gels were placed on the Pharmacia FBE-3000 Flatbed unit with sample wells towards the anode. Electrode strips were soaked in 0.5 M sodium hydroxide (cathode) and 0.5 M acetic acid (anode) and gels were run at 10°C for 20 min at 100 v followed by 15 min at 500 v.
Immunofixation was carried out by overlaying the gel with cellulose acetate strips soaked in specific antibody. Sheep antisera raised against K or A light chains were purified by immunosorption (Pierson et al., 1980) and then deaggregated on columns of Ultrogel AcA 34 (LKB-Produkter AB, Bromma, Sweden). They were then used at a concentration of I mg ml-1. After exposure for 1 h in a humid chamber the gels were thoroughly washed with 0.9% saline and then with distilled water followed by methanol. After drying at 70°C gels were stained with 0.3% Coomassie Brilliant Blue R dissolved in methanol-acetic acid-distilled water (4:4:1) and destained until the background was clear.
Autoradiography
This technique was used where the expected concentration of monoclonal light chain applied to the gel was 3 /,g ml-1; sensitivity was increased to -4 times that of immunofixation alone. It was necessary for analysis of concentrated culture fluids. In this case the gel was treated with sheep antibody as described above and washed in saline followed by distilled water. It was then overlaid with a cellulose acetate strip soaked in the radiolabelled second antibody. This was a preparation of rabbit anti-sheep IgG, purified by immunosorption on Sepharose-sheep IgG and radiolabelled by the lactoperoxidase-catalyzed iodination using 1251I (Amersham U.K.) to a specific activity of 2 uCi Mg-1; it was used at a concentration of 25 ug ml -1. After 1 h in a humid chamber the gel was washed and then dried. It was then placed in contact with X-ray film (X-Omat S, Kodak Ltd.), in the dark for 2 days before being developed.
Cell culture
Leukaemic lymphocytes were prepared from peripheral blood of 2 patients (JW and LP in Table  I ) with CLL by gradient centrifugation on FicollHypaque (Boyum, 1974) as described previously . Cells were thoroughly Figure: in this case the A chain was unusually acidic and it can be seen that the same 2 well-defined bands are present in both culture fluid and urine. Extra bands in the urine are visible at the relatively high concentration applied.
The results of analysis of urine from the patients with NHL are shown in Table II . Assessment is more difficult in this case due to the heterogeneous nature of the disease and to the fact that therapy is often given. In the patients investigated, 7 out of 22 showed a monoclonal light chain. However, subsequent histological assessment showed that 3 patients (WW, PG and EF in Table II had rather than B lymphocytes, and a further 2 patients (RR and BW) had enlarged lymph nodes with the histological appearance of immunological reactivity rather than tumour involvement. One patient (JU) showed a histological appearance consistent with angioimmunoblastic lymphadenopathy. This is a lymphoproliferative disease not thought to involve neoplastic B lymphocytes (Lukes & Tindle, 1975 , 1980) . In cells exporting an excess of free light chains it may be expected that they will appear eventually in the urine where they can both aid in diagnosis of a B cell tumour and also provide an index of tumour load (Pierson et al., 1980) . Methods used previously to examine urine for tumour-related light chains have relied on changes in the levels of one of the light chain types. Results then have to be interpreted against a wide range of KI/ ratios in normal subjects. Using such a procedure, significant increases in the level of one of the urinary light chain types were seen in 19 out of 76 cases of lymphoma and leukaemia (Lindstr6m et al., 1969) .
The presence of such monoclonal light chain in urine from patients with B cell tumours has been sought in a previous study from this laboratory and 40-50% of patients with CLL and NHL were found to be positive (Pierson et al., 1980 The incidence of monoclonal urinary light chain in NHL involving B lymphocytes appears to be lower than for CLL (7 out of 16 patients studied). Several factors could account for this: 6 of the patients studied were already on treatment and although 2 of these did have urinary monoclonal light chains, the effect of treatment on the remaining 4 is not known. A further study of patients before treatment is in progress. Another factor is the stage of the disease, as a small body load would not be expected to give rise to detectable light chain: however no obvious correlation with disease stage is apparent from Table II . The third factor is the nature of the tumour cells, in that the more mature B cells may not export excess light chain (Hannam-Harris et al., 1980) . Even with these restrictions, the finding of monoclonal light chain in the urine of a patient would be a useful immunochemical adjunct to current diagnostic procedures, although it should be emphasized that failure to detect such a product would not preclude a B cell neoplasm. Histological investigation of biopsy material from patients with suspected NHL, even with analysis of surface Ig, may fail to distinguish the nature of the disease and urine analysis would provide a simple additional test. Also, for both CLL and NHL the load of a tumour-related product in urine would give a measure of total body load and quantitative estimation of urinary light chain e.g. by radioimmunoassay during a course of therapy may be useful in monitoring patients.
One problem which could arise is that of "idiopathic" Bence-Jones proteinuria, particularly when Lising such a sensitive method of analysis. The cxistence of sLIch a state has been questioned recently (Kyle & Greipp, 1982) A further extension of these findings is that isolation of monoclonal light chains from selected patients can be used to raise anti-light chain isotypes (Pierson et al., 1980) . If these react with idiotypic determinants on the tumour cells as has been demonstrated for a B lymphocytic neoplasm of guinea pigs (Stevenson et al., 1977) , it may be possible to use such antibody in analysis of tumour distribution and possible immunotherapy.
